Literature DB >> 32659858

In vivo immunotoxicity of Gd2 O3 :Eu3+ nanoparticles and the associated molecular mechanism.

Cunjing Zheng1, Xiumei Tian2, Jing Cai3, Long Huang4, Shunxin Wang1, Fanwen Yang2, Yanping Ma2, Fukang Xie1, Li Li3.   

Abstract

The in vivo toxicity of Gd2 O3 :Eu3+ nanoparticles (NPs) used as dual-modal nanoprobes for molecular imaging has not been studied, and the corresponding molecular mechanism of immunotoxicity remains unknown. In this study, we investigated the cytotoxicity, in vitro apoptosis, and in vivo immunotoxicity of Gd2 O3 :Eu3+ NPs. The NPs showed little immunotoxicity to BALB/c mice. We explored the possible role of the phosphoinositide 3-kinase (PI3K) signaling pathway and found that reactive oxygen species could act as secondary messengers in cellular signaling, inhibiting PI3K expression in the liver. The immune suppression caused by PI3K inhibition helped the mice adapt to stress. The immunotoxicities caused by Gd2 O3 :Eu3+ and gadodiamide, a commonly used contrast agent, were not significantly different, and the mice were able to tolerate the immunotoxicity caused Gd2 O3 :Eu3+ NPs in vitro and in vivo experiments. The results suggest that Gd2 O3 :Eu3+ NPs are sufficiently biocompatible to be used safely in preclinical applications and show promise as bio-imaging agents. Moreover, the in vivo molecular mechanism of immunotoxicity caused by the Gd2 O3 :Eu3+ NPs provides a platform for further research on the immunotoxicity of nano-sized biomaterials.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  ROS; biocompatibility; immunosuppression; immunotoxicity; nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 32659858     DOI: 10.1002/jbt.22562

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  1 in total

1.  Nanohydroxyapatite as a Biomaterial for Peripheral Nerve Regeneration after Mechanical Damage-In Vitro Study.

Authors:  Benita Wiatrak; Paulina Sobierajska; Marta Szandruk-Bender; Paulina Jawien; Maciej Janeczek; Maciej Dobrzynski; Patrycja Pistor; Adam Szelag; Rafal J Wiglusz
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.